XERS
Xeris Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XERS Filings
Filing Date
Form Description
Form Type
2025-12-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-01
Form 8-K - Current report
Key Events
2025-12-01 · Key Events
Form 8-K - Current report
2025-11-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-13
Form 144 - Report of proposed sale of securities
Ownership
2025-11-13 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 144 - Report of proposed sale of securities
Ownership
2025-11-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-06
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-06
Form 8-K - Current report
Key Events
2025-11-06 · Key Events
Form 8-K - Current report
2025-10-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
